ProfileGDS5678 / 1421078_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 45% 43% 57% 43% 42% 44% 44% 42% 42% 43% 43% 42% 43% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0824945
GSM967853U87-EV human glioblastoma xenograft - Control 22.996243
GSM967854U87-EV human glioblastoma xenograft - Control 33.4696757
GSM967855U87-EV human glioblastoma xenograft - Control 42.9335743
GSM967856U87-EV human glioblastoma xenograft - Control 52.9155942
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1112444
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0820544
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.968942
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9594642
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9826443
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9940943
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9275642
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9919743
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9984143